Trigeminal Neuralgia - Case Report and Review
Trigeminal Neuralgia - Case Report and Review
Trigeminal Neuralgia - Case Report and Review
and Review
Benjamin M. Zussman, BS1; Yaron A. Moshel, MD PhD2
Jefferson Medical College, Philadelphia, PA
Neurosurgery Department, Thomas Jefferson University Hospitals, Philadelphia, PA
1
2
PATIENT VIGNETTE
We report the case of an 86-year-old female who described 15-years of sharp, stabbing pain that
radiated down the distribution of the second and third divisions of her right trigeminal nerve. She
described two trigger points, one on her right cheek and a second intra-oral trigger. Her symptoms
were often triggered by eating and she had begun to loose weight secondary to the pain. She denied
having any baseline pain between the episodes of lancinating pain. She denied any contralateral pain,
dysasthetic pain or any burning pain sensation. She denied any pain along the first trigeminal division
and did not recently undergo any dental work or have a history of dental carries. Her symptoms had
been initially well controlled with Carbamazepine 200 mg BID, but had recently worsened despite
increasing the dosage to 600 mg BID when she started to develop medication-related side effects.
Her past medical history was unremarkable, and on examination she was neurologically intact. Her
brain magnetic resonance imaging (MRI) showed no masses or gross abnormalities, and she was
diagnosed with trigeminal neuralgia.
Neurosurgical intervention was pursued because the patient was refractory to medical therapy and
had worsening symptoms. Non-invasive Gamma Knife radiosurgery was recommended because
of the patients surgical risk profile and preference for a non-invasive procedure. Using Leksell
stereotactic frame, a stereotactic MRI dataset was generated with a gradient echo and CISS sequence.
On the Leksell gamma planning workstation we identified the right trigeminal nerve and prescribed
90 Gy to the 100% isodose line using a single 4-mm shot such that the 20% isodose line was tangential
to the brainstem. The patient tolerated the procedure well and reported complete resolution of her
symptoms at one-month follow-up.
DISCUSSION
For patients complaining of facial pain, the differential diagnosis is broad. It includes dental
abnormalities, such as caries, root abscesses,
and broken teeth; temporomandibular joint
pain; eye pain due to glaucoma, orbital cellulitis,
or trauma; facial trauma including bony fractures; tumors of the facial bones or infiltrating
the trigeminal nerve; giant cell arteritis; trigeminal autonomic cephalgias, such as cluster
headache and paroxysmal hemicrania; primary
headache syndromes including migraine and
tension types; postherpatic neuralgia; systemic
autoimmune disorders including lupus erythematosis; and other structural pathology, such as
cerebellopontine angle tumors and cysts.1
The International Headache Society (ihsclassification.org) defines classical trigeminal
neuralgia as follows: (1) Paroxysmal attacks of
pain lasting from a fraction of a second to two
minutes, affecting one or more divisions of the
trigeminal nerve; (2) Pain has at least one of
Figure 1
Figure 2
JHN JOURNAL
Pain
HISTORICAL CONTEXT
The earliest reported case of trigeminal
neuralgia was Johannes Laurentis Bausch
(1605-1665), physician and president of the
Imperial Leopoldian Academy of Natural
Sciences. Bausch himself suffered from severe
trigeminal neuralgia, and the course of his
illness was detailed in his eulogy, which was
published posthumously by the Academy.4
Next, John Locke (1632-1704), physician and
famed philosopher, was summoned to visit the
Countess of Northumberland (wife of an English Ambassador), who suffered from crippling
trigeminal neuralgia. Locke recorded the case.4.
Figure 3
Locke (National Library of Medicine)
More recently, Burchiel and colleagues2 developed a simplified framework for defining and
classifying trigeminal neuralgia (Table 1).
Importantly, trigeminal neuralgia traditionally
referred to as classical-type is redefined as TN1,
while idiopathic facial pain that is aching, throbbing, or burning for more than 50% of the time
(constant pain) is termed TN2. This distinction
between shock-like (TN1) and constant (TN2)
pain is the most significant predictor of longterm success after treatment.3
Preoperative MRI is useful to rule out any other
potential pathological etiologies such as tumor
or demyelinating disease. More advanced MR
imaging can identify the presence of vascular
compression at the root entry zone, which
can aid pre-operative planning. Nevertheless,
Figure 5
Figure 4
Hunter (National Library of Medicine)
JHN JOURNAL
Defining Symptomatology
Idiopathic
TN1
TN2
Trigeminal Injury
Neuropathic Pain
Deafferentation Pain
Symptomatic
Postherpetic
PATHOGENESIS
Our understanding of the pathogenesis of
trigeminal neuralgia continues to evolve. The
leading explanation involves trigeminal nerve
root compression that causes demyelination.
Multiple different anatomical variants (classically the superior cerebellar artery) may
cause arterial and/or venous compression of
the trigeminal nerve root, usually within a few
millimeters of its entry into the brainstem.8
Pathological analyses demonstrate a focal
zone of chronic demyelination immediately
beneath the region of nerve indentation and
limited to the immediate vicinity of the point
of vascular indentation.9
In turn, this demyelination causes ectopic
(erratic) impulses and ephaptic (indirect)
cross-firing between nerve fibers. Experimental evidence from a model of purposefully
demyelinated nerve fibers in cat dorsal spinal
cord white matter demonstrates spontaneous,
ectopic activity.10 Ephaptic coupling refers to
the indirect firing that occurs between neural
fibers through extracellular electrical fields,
JHN JOURNAL
TREATMENTS
Medical therapy for trigeminal neuralgia
includes anticonvulsant drugs. In 1963
Carbamazepines efficacy in treating this disorder was first demonstrated by Sigfrid Blom.13
Carbamazepine stabilizes inactivated voltagegated sodium channels, down-regulating
cellular excitability. It remains the first-line
drug of choice today. Alternative medications
include Oxcarbazepine, Baclofen, Gabapentin,
Lamotrigine, and Pimozide.
Pain
REFERENCES
JHN JOURNAL